A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Clinical trial NCT01986101 · COMPLETED

Trial details

NCT number: NCT01986101
Sponsor: Sumitomo Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Depression

Start date: 2014-02-19
Primary completion: 2017-02-01
Enrollment: 525

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.